thefederalregister.org Federal Register Research Archive

Document

Notice of Public Hearing: NIAID Proposed Reorganization

Pursuant to the NIH Reform Act of 2006 (42 U.S.C. 281(d)(4)), notice is hereby given that the National Institute of Allergy and Infectious Diseases (NIAID) of the National Insti...

PDF versionFederalRegister.gov
Department of Health and Human Services
National Institutes of Health

AGENCY:

National Institutes of Health, HHS.

ACTION:

Notice.

SUMMARY:

Pursuant to the NIH Reform Act of 2006 (42 U.S.C. 281(d)(4)), notice is hereby given that the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) will be accepting comments on a proposed reorganization involving the Division of Clinical Research (DCR).

DATES:

Comments regarding this proposed reorganization are best assured of having their full effect if received from September 14th, 2026-September 18th, 2026.

ADDRESSES:

Information on the proposed reorganization can be found at: www.niaid.nih.gov/​about/​niaid-organization-DCR. The following email address is being provided for comments on the reorganization . The Website will be active September 14th through September 18th, 2026.

FOR FURTHER INFORMATION CONTACT:

For additional questions about this proposed reorganization contact: Katherine Beck, Acting Executive Officer, National Institute of Allergy and Infectious Diseases, 5601 Fishers Lane, Rockville, MD 20892.

SUPPLEMENTARY INFORMATION:

NIAID's proposal to implement organizational changes involving the Division of Clinical Research (DCR). The goal for the reorganization is to abolish several offices and the Division of Clinical Research (DCR) and realign the clinical operations and oversight across multiple NIAID components. The proposed reorganization aims to better align with Presidential priorities and to reflect the Institute's updated vision and revised mission focus while continuing important research to benefit the ( printed page 55892) American public with proper oversight and transparency.

John H. Powers III,

Acting Director, National Institute of Allergy and Infectious Diseases.

[FR Doc. 2026-17685 Filed 8-28-26; 8:45 am]

BILLING CODE 4140-01-P

Legal Citation

Federal Register Citation

Use this for formal legal and research references to the published document.

91 FR 55891

Web Citation

Suggested Web Citation

Use this when citing the archival web version of the document.

“Notice of Public Hearing: NIAID Proposed Reorganization,” thefederalregister.org (August 31, 2026), https://thefederalregister.org/documents/2026-17685/notice-of-public-hearing-niaid-proposed-reorganization.